• LAST PRICE
    10.8200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    10.5000/ 1
  • Ask / Lots
    13.0000/ 78
  • Open / Previous Close
    0.0000 / 10.8200
  • Day Range
    ---
  • 52 Week Range
    Low 3.5500
    High 17.7911
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 10.85
TimeVolumeOLMA
09:32 ET895810.63
09:34 ET50010.72
09:36 ET10010.65
09:38 ET379210.625
09:39 ET315110.74
09:41 ET47510.74
09:43 ET130010.64
09:45 ET10010.6
09:48 ET111510.69
09:50 ET90110.69
09:52 ET60010.62
09:54 ET40010.62
09:56 ET130010.63
09:57 ET20010.64
09:59 ET21010.66
10:03 ET169510.685
10:06 ET70010.71
10:08 ET79810.69
10:12 ET10010.7
10:14 ET75110.73
10:15 ET483510.855
10:19 ET20010.83
10:21 ET20010.79
10:26 ET20010.78
10:30 ET41210.79
10:32 ET139210.8
10:33 ET78110.73
10:35 ET210010.73
10:37 ET75510.7301
10:39 ET11910.76
10:42 ET80010.83
10:46 ET10210.84
10:48 ET30010.83
10:50 ET10010.835
10:51 ET120010.85
10:53 ET150710.85
10:57 ET62510.82
11:00 ET27910.83
11:02 ET22110.85
11:04 ET10010.86
11:06 ET10010.9
11:08 ET20010.88
11:09 ET40010.934
11:11 ET55510.925
11:13 ET10010.937
11:15 ET119710.97
11:18 ET232510.93
11:20 ET20910.92
11:22 ET100010.9
11:24 ET40010.92
11:27 ET20410.915
11:29 ET52410.955
11:31 ET678010.97
11:38 ET13510.95
11:40 ET42010.94
11:44 ET31710.94
11:45 ET41910.92
11:47 ET21910.91
11:49 ET43410.91
11:51 ET40110.91
11:54 ET10010.91
11:58 ET30910.9
12:00 ET20010.9
12:02 ET36910.88
12:03 ET70310.89
12:05 ET30510.88
12:07 ET40410.895
12:12 ET70710.895
12:14 ET60110.89
12:16 ET172810.86
12:18 ET10010.84
12:20 ET21610.83
12:21 ET20210.83
12:25 ET50010.84
12:27 ET10010.835
12:30 ET56910.82
12:32 ET50010.83
12:36 ET40010.81
12:38 ET22010.815
12:39 ET36010.83
12:45 ET63010.82
12:48 ET72010.82
12:56 ET36310.83
12:57 ET74910.815
12:59 ET20010.82
01:01 ET30010.805
01:03 ET10010.8
01:06 ET10010.78
01:08 ET60010.76
01:12 ET126310.76
01:14 ET139710.785
01:15 ET101110.7999
01:17 ET30010.82
01:19 ET10010.82
01:21 ET95610.8
01:26 ET30010.78
01:28 ET10010.8
01:30 ET20010.78
01:32 ET261910.73
01:33 ET70010.74
01:35 ET150010.77
01:37 ET40010.76
01:39 ET30010.76
01:42 ET20010.78
01:44 ET10010.78
01:46 ET30010.78
01:50 ET10010.77
01:51 ET10010.76
01:53 ET10010.75
01:55 ET30010.78
02:02 ET60010.77
02:06 ET40010.8
02:08 ET30010.83
02:09 ET104310.85
02:13 ET140010.84
02:15 ET405010.83
02:18 ET30010.82
02:20 ET100010.77
02:22 ET112410.77
02:24 ET20010.78
02:26 ET20010.78
02:29 ET40010.77
02:31 ET90010.75
02:33 ET84210.76
02:36 ET39210.78
02:38 ET10010.79
02:40 ET669610.83
02:44 ET183410.81
02:51 ET158710.83
02:54 ET50010.855
02:58 ET49810.87
03:00 ET30010.865
03:02 ET30010.87
03:03 ET120710.86
03:05 ET56410.84
03:07 ET60010.84
03:09 ET12510.845
03:12 ET30010.85
03:14 ET38710.86
03:16 ET96210.85
03:18 ET50010.84
03:20 ET34410.855
03:21 ET70510.845
03:23 ET82010.86
03:25 ET50010.87
03:27 ET10010.87
03:30 ET175310.84
03:34 ET70010.801
03:36 ET140010.8
03:38 ET254910.811
03:39 ET60010.83
03:41 ET70910.81
03:43 ET10010.82
03:45 ET183910.825
03:48 ET198710.84
03:50 ET118410.82
03:52 ET50010.83
03:54 ET164910.815
03:56 ET396310.815
03:57 ET368710.801
03:59 ET1043510.82
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOLMA
Olema Pharmaceuticals Inc
605.0M
-5.0x
---
United StatesATXS
Astria Therapeutics Inc
609.4M
-4.7x
---
United StatesCMPS
Compass Pathways PLC
600.0M
-3.7x
---
United StatesMLYS
Mineralys Therapeutics Inc
599.0M
-6.7x
---
United StatesLYEL
Lyell Immunopharma Inc
612.4M
-2.6x
---
United StatesLBPH
Longboard Pharmaceuticals Inc
613.3M
-7.6x
---
As of 2024-04-17

Company Information

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of targeted therapies for women's cancers. Its lead product candidate, OP-1250, is an oral therapy with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). The Company's OP-1250 is an oral small molecule clinical-stage product candidate for the treatment of endocrine-driven cancers. OP-1250, both as a monotherapy and in combination with inhibitors of cyclin-dependent kinase four and six (CDK4/6) demonstrated robust tumor shrinkage in several xenograft models, including ESR1 and PIK3CA mutations and central nervous system (CNS), metastasis. It is in the Phase I/ II clinical trial, and in Phase Ib/ II combination with palbociclib, in patients with metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer.

Contact Information

Headquarters
780 Brannan StreetSAN FRANCISCO, CA, United States 94103
Phone
415-651-3316
Fax
302-674-5266

Executives

Director
Ian Clark
President, Chief Executive Officer, Director
Sean Bohen
Chief Operating and Financial Officer
Shane Kovacs
Executive Vice President, Chief Legal Officer and Secretary
John Moriarty
Chief Discovery and Non-Clinical Development Officer
David Myles

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$605.0M
Revenue (TTM)
$0.00
Shares Outstanding
55.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.08
EPS
$-2.16
Book Value
$4.62
P/E Ratio
-5.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.